NO20054647L - Anvendelse av isoquinolinderivater for behandling av kreft og map kinase relaterte sykdommer - Google Patents

Anvendelse av isoquinolinderivater for behandling av kreft og map kinase relaterte sykdommer

Info

Publication number
NO20054647L
NO20054647L NO20054647A NO20054647A NO20054647L NO 20054647 L NO20054647 L NO 20054647L NO 20054647 A NO20054647 A NO 20054647A NO 20054647 A NO20054647 A NO 20054647A NO 20054647 L NO20054647 L NO 20054647L
Authority
NO
Norway
Prior art keywords
treatment
map kinase
cancer
related diseases
isoquinoline derivatives
Prior art date
Application number
NO20054647A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054647D0 (no
Inventor
Timothy Michael Ramsey
Michael Lloyd Sabio
David Batt
Guldo Bold
Sunkyu Kim
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20054647D0 publication Critical patent/NO20054647D0/no
Publication of NO20054647L publication Critical patent/NO20054647L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20054647A 2003-03-11 2005-10-10 Anvendelse av isoquinolinderivater for behandling av kreft og map kinase relaterte sykdommer NO20054647L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45362403P 2003-03-11 2003-03-11
PCT/EP2004/002460 WO2004080464A1 (fr) 2003-03-11 2004-03-10 Utilisation de derives d'isoquinoline aux fins du traitement de cancers et d'etats pathologiques lies a la kinase associee aux membranes (map)

Publications (2)

Publication Number Publication Date
NO20054647D0 NO20054647D0 (no) 2005-10-10
NO20054647L true NO20054647L (no) 2005-12-09

Family

ID=32990797

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054647A NO20054647L (no) 2003-03-11 2005-10-10 Anvendelse av isoquinolinderivater for behandling av kreft og map kinase relaterte sykdommer

Country Status (22)

Country Link
EP (1) EP1603566B1 (fr)
JP (1) JP2006519807A (fr)
KR (1) KR20050108383A (fr)
CN (1) CN1758910A (fr)
AT (1) ATE421324T1 (fr)
AU (1) AU2004218914A1 (fr)
BR (1) BRPI0408257A (fr)
CA (1) CA2518530A1 (fr)
DE (1) DE602004019193D1 (fr)
ES (1) ES2318276T3 (fr)
HR (1) HRP20050788A2 (fr)
IS (1) IS8064A (fr)
MA (1) MA27724A1 (fr)
MX (1) MXPA05009687A (fr)
NO (1) NO20054647L (fr)
PL (1) PL1603566T3 (fr)
PT (1) PT1603566E (fr)
RU (1) RU2325159C2 (fr)
TN (1) TNSN05223A1 (fr)
TW (1) TW200501955A (fr)
WO (1) WO2004080464A1 (fr)
ZA (1) ZA200506571B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4939220B2 (ja) 2003-05-15 2012-05-23 アークル インコーポレイテッド ｐ３８の阻害物質としてのイミダゾチアゾール類およびイミダゾオキサゾール誘導体
AR045944A1 (es) * 2003-09-24 2005-11-16 Novartis Ag Derivados de isoquinolina 1.4-disustituidas
US7829560B2 (en) 2004-07-08 2010-11-09 Arqule, Inc. 1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase
WO2006044869A1 (fr) 2004-10-19 2006-04-27 Arqule, Inc. Synthese d'inhibiteurs d'imidazo-oxazole et d'imidazothiazole de la map kinase p38
CN101160131A (zh) * 2005-02-25 2008-04-09 诺瓦提斯公司 Bcr-abl和raf抑制剂的药物组合产品
HRP20110839T1 (hr) * 2005-07-26 2011-12-31 Sanofi Derivati cikloheksaminizokinolona kao inhibitori rho-kinaze
EP2046753A2 (fr) 2006-07-06 2009-04-15 Brystol-Myers Squibb Company Inhibiteurs de type i de la 11-bêta hydroxystéroïde déshydrogénase pyridone/hydroxypyridine
CA2639416C (fr) * 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Test de diagnostic pour la susceptibilite aux inhibiteurs de la b-raf kinase
US20110152770A1 (en) 2009-07-30 2011-06-23 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
CN103038364A (zh) 2010-03-09 2013-04-10 达纳－法伯癌症研究所公司 诊断和治疗具有或发展对于第一种癌症治疗的抗性的患者中的癌症的方法
AU2011320565A1 (en) 2010-10-28 2013-05-23 Innocrin Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CN103435430B (zh) * 2013-08-08 2015-02-18 四川大学 一种还原酰胺类化合物的方法
KR102119943B1 (ko) 2018-05-23 2020-06-05 주식회사 포스코 시편배치유닛 및 이를 포함하는 도장밀착성 실험장치
WO2020007807A1 (fr) * 2018-07-02 2020-01-09 Ecole Polytechnique Federale De Lausanne (Epfl) Composés favorisant le lactate et leurs utilisations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
WO2000009495A1 (fr) * 1998-08-11 2000-02-24 Novartis Ag Derives d'isoquinoline possedant une activite d'inhibition de l'angiogenese
DOP2000000070A (es) * 1999-09-28 2002-02-28 Bayer Healthcare Llc Piridinas y piridacinas sustituidas con actividad de inhibición de angiogénesis
WO2001058899A1 (fr) * 2000-02-09 2001-08-16 Novartis Ag Derives de pyridine inhibant l'angiogenese et/ou la tyrosine-kinase du recepteur de vegf
WO2002060392A2 (fr) * 2001-01-31 2002-08-08 Synaptic Pharmaceutical Corporation Utilisation d'antagonistes du recepteur gal3 dans le traitement de la depression et/ou de l'anxiete et composes utiles dans de telles methodes
CA2439263C (fr) * 2001-03-02 2012-10-23 Frank Becker Systeme de dosage a trois hybrides
CA2471314A1 (fr) * 2001-12-21 2003-07-24 Bayer Pharmaceuticals Corporation Polytherapies antiangiogeneses a base de derives de pyridazine ou pyridine
US7220775B2 (en) * 2002-08-07 2007-05-22 H. Lundbeck A/S Compound useful for the treatment of neuropathic pain

Also Published As

Publication number Publication date
NO20054647D0 (no) 2005-10-10
RU2005131168A (ru) 2006-05-27
CA2518530A1 (fr) 2004-09-23
PT1603566E (pt) 2009-04-27
MA27724A1 (fr) 2006-01-02
ES2318276T3 (es) 2009-05-01
CN1758910A (zh) 2006-04-12
KR20050108383A (ko) 2005-11-16
DE602004019193D1 (de) 2009-03-12
JP2006519807A (ja) 2006-08-31
EP1603566B1 (fr) 2009-01-21
HRP20050788A2 (en) 2006-12-31
RU2325159C2 (ru) 2008-05-27
WO2004080464A1 (fr) 2004-09-23
AU2004218914A1 (en) 2004-09-23
BRPI0408257A (pt) 2006-03-07
EP1603566A1 (fr) 2005-12-14
MXPA05009687A (es) 2005-10-20
PL1603566T3 (pl) 2009-07-31
IS8064A (is) 2005-10-10
ZA200506571B (en) 2006-07-26
ATE421324T1 (de) 2009-02-15
TNSN05223A1 (en) 2007-06-11
TW200501955A (en) 2005-01-16

Similar Documents

Publication Publication Date Title
TNSN06093A1 (en) 1,4- disubstituted isoquinoline derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
NO20054647L (no) Anvendelse av isoquinolinderivater for behandling av kreft og map kinase relaterte sykdommer
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
NO330981B1 (no) Indol- eller benzimidazolderivater for modulering av IkB-kinase, fremgangsmate for fremstilling av disse, legemiddel og anvendelse av forbindelsene
EA200700321A1 (ru) Пиразолзамещённые аминогетероарильные соединения в качестве ингибиторов протеинкиназы
BRPI0411365A (pt) derivados de aminopiridina
ATE218549T1 (de) Verbindungen als pde iv und tnf inhibitoren
CY1108267T1 (el) Ενωσεις που επηρεαζουν τη γλυκοκιναση
ATE402929T1 (de) Pyrazinverbindungen als inhibitoren des transforming growth factor (tgf)
UA96565C2 (ru) Пиридильные ингибиторы хеджхоговской передачи сигнала
NO20051339L (no) Anvendelse av lkB-kinaseinbibitorer ved behandling av smerte.
YU21401A (sh) Tetrahidropiridoetri
ATE362929T1 (de) Pyridinderivate als inhibitoren der raf-kinase
NO20026242L (no) Syntesemetoder for aplidin og nye antitumorale derivater, metoder for deresfremstilling og anvendelse av disse
EA200800516A1 (ru) Производные n-фенил-2-пиримидинамина и процесс их получения
DE602004023271D1 (de) Metastin derivate und ihre verwendung
NO20073839L (no) Kinolinderivat, fremgangsmate for fremstilling og anvendelse av dette, og legemiddel inneholdende dette
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
NO20050640L (no) Rutenium anticancer komplekser
ATE482955T1 (de) Azabicyclooctan-3-onderivate und deren verwendung
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE523199T1 (de) Pyridazinverbindungen und verfahren
NO20055650L (no) Ruteinum (II)-komplekser for behandling av tumorer
DE60120398D1 (de) Imidazopyridin-8-one

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application